SCHEMBL129269

SCHEMBL129269

CCCCCCCCCCCCc1ccccc1[I+]c1ccccc1CCCCCCCCCCCC.Fc1c(F)c(F)c([B-](c2c(F)c(F)c(F)c(F)c2F)(c2c(F)c(F)c(F)c(F)c2F)c2c(F)c(F)c(F)c(F)c2F)c(F)c1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIPG Q9Y5X9 1/20 0.43
NR1H2 P55055 1/20 0.37
NR1H3 Q13133 1/20 0.37
CYSLTR2 Q9NS75 6/20 0.36
CYSLTR1 Q9Y271 6/20 0.36
ALOX5 P09917 2/20 0.36
MEN1 O00255 1/20 0.36
TP53 P04637 1/20 0.36
CYP3A4 P08684 1/20 0.36
MAPT P10636 1/20 0.36
TYR P14679 1/20 0.36
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36
HTT P42858 1/20 0.36
KMT2A Q03164 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
BID P55957 3/20 0.35
MCL1 Q07820 3/20 0.35
BCL2L1 Q07817 2/20 0.35
BAK1 Q16611 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29362662 1.00 LIPG (0.43) LIPGNR1H2NR1H3CYSLTR2CYSLTR1
SCHEMBL4730366 0.94 LIPG (0.35) LIPGNR1H2NR1H3CYSLTR2CYSLTR1
SCHEMBL29584401 0.85 LIPG (0.50) LIPGNR1H2NR1H3CYSLTR2CYSLTR1
SCHEMBL132626 0.85 LIPG (0.50) LIPGNR1H2NR1H3CYSLTR2CYSLTR1
SCHEMBL5413206 0.85 LIPG (0.50) LIPGNR1H2NR1H3CYSLTR2CYSLTR1
SCHEMBL123866 0.84 LIPG (0.56) LIPGNR1H2NR1H3CYSLTR2CYSLTR1
SCHEMBL11149596 0.84 LIPG (0.56) LIPGNR1H2NR1H3CYSLTR2CYSLTR1
SCHEMBL29470133 0.84 LIPG (0.56) LIPGNR1H2NR1H3CYSLTR2CYSLTR1
SCHEMBL5027433 0.84 LIPG (0.56) LIPGNR1H2NR1H3CYSLTR2CYSLTR1
Hydrochloric Acid SCHEMBL8180220 0.83 LIPG (0.55) LIPGNR1H2NR1H3CYSLTR2CYSLTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 579 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2513722-B1 LED CURABLE LIQUID RESIN COMPOSITIONS FOR ADDITIVE FABRICATION, PROCESS FOR MAKING A THREE-DIMENSIONAL OBJECT USING THE SAME DSM IP ASSETS BV (NL) 2017-01-25 EP claimed
WO-2014170799-A1 CROSSLINKABLE VARNISH AND METHOD FOR APPLYING SAME COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2014-10-23 WO claimed
US-8415081-B2 Photosensitive resin composition having a high refractive index CORNELL RESEARCH FOUNDATION, INC. (US) 2013-04-09 US claimed
EP-2513722-A1 LED CURABLE LIQUID RESIN COMPOSITIONS FOR ADDITIVE FABRICATION DSM IP Assets B.V. (NL) 2012-10-24 EP claimed
US-20120259031-A1 LED CURABLE LIQUID RESIN COMPOSITIONS FOR ADDITIVE FABRICATION DSM IP ASSETS, B.V. (NL) 2012-10-11 US claimed
WO-2011075555-A1 LED CURABLE LIQUID RESIN COMPOSITIONS FOR ADDITIVE FABRICATION DSM IP ASSETS, B.V. (NL) 2011-06-23 WO claimed
US-20110003123-A1 SENSITIZER/INITIATOR COMBINATION FOR NEGATIVE-WORKING THERMAL-SENSITIVE COMPOSITIONS USABLE FOR LITHOGRAPHIC PLATES KODAK GRAPHIC COMMUNICATIONS, GMBH (DE) 2011-01-06 US claimed
WO-2009109579-A1 SENSITIZER/INITIATOR COMBINATION FOR NEGATIVE-WORKING THERMAL-SENSITIVE COMPOSITIONS USABLE FOR LITHOGRAPHIC PLATES EASTMAN KODAK COMPANY (US) 2009-09-11 WO claimed
EP-2098367-A1 Sensitizer/Initiator Combination for Negative-Working Thermal-Sensitive Compositions Usable for Lithographic Plates EASTMAN KODAK COMPANY (US) 2009-09-09 EP claimed
EP-2021873-A1 NEGATIVE-WORKING RADIATION-SENSITIVE COMPOSITIONS AND IMAGEABLE MATERIALS EASTMAN KODAK COMPANY (US) 2009-02-11 EP claimed
US-20080038665-A1 Photosensitive Resin Composition Having a High Refractive Index HITACHI CHEMICAL CO., LTD. (JP) 2008-02-14 US claimed
JP-2008502938-A 2008-01-31 JP claimed
WO-2007139687-A1 NEGATIVE-WORKING RADIATION-SENSITIVE COMPOSITIONS AND IMAGEABLE MATERIALS EASTMAN KODAK COMPANY (US) 2007-12-06 WO claimed
US-20070275322-A1 Negative-working radiation-sensitive compositions and imageable materials EASTMAN KODAK COMPANY 2007-11-29 US claimed
WO-2006009526-A1 PHOTOSENSITIVE RESIN COMPOSITION HAVING A HIGH REFRACTIVE INDEX CORNELL RESEARCH FOUNDATION, INC. (US) 2006-01-26 WO claimed
US-6204350-B1 POLYMER HAVING REACTIVE END GROUPS 3M INNOVATIVE PROPERTIES COMPANY 2001-03-20 US claimed
EP-0966503-A1 CURE-ON-DEMAND, MOISTURE-CURABLE COMPOSITIONS HAVING REACTIVE SILANE FUNCTIONALITY MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1999-12-29 EP claimed
WO-1998040439-A1 CURE-ON-DEMAND, MOISTURE-CURABLE COMPOSITIONS HAVING REACTIVE SILANE FUNCTIONALITY MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1998-09-17 WO claimed
US-20260062548-A1 RUBBER-BONDED CELLULOSE FIBERS AND MANUFACTURING METHOD THEREFOR, RESIN COMPOSITION AND MANUFACTURING METHOD THEREFOR, AND CURABLE RESIN COMPOSITION KUREHA CORPORATION (JP) 2026-03-05 US disclosed
US-5340898-A A mixtures comprising an ionic onium borate photoinitiators; nontoxic RHONE-POULENC CHIMIE (FR) 1994-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260062548-A1 RUBBER-BONDED CELLULOSE FIBERS AND MANUFACTURING METHOD THEREFOR, RESIN COMPOSITION AND MANUFACTURING METHOD THEREFOR, AND CURABLE RESIN COMPOSITION CROCC, WASF2, DCXR LIPG 2603/4885NR1H2 2063/4885NR1H3 2157/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.